FDA’s Plan To Collect Pathogen Samples Revives Walden’s Concerns

By David Roza
August 14, 2019 at 3:48 PM
House Energy & Commerce Committee ranking Republican Greg Walden (OR) tells Inside Health Policy he is concerned about FDA’s plan to collect pathogen samples for an infectious disease database, considering the agency has not followed through on its pledge to improve its procedures for securing, storing and accounting for dangerous pathogens. The lawmaker says he is worried by the continued lack of resources and personnel in FDA’s Office of Laboratory Science and Safety (OLSS), which is responsible for ensuring...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.